Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,450 total articles
SRX Global, an AI-driven investment platform, announced a board-approved 60-to-1 consolidation of its issued and outstanding common stock, effective July 6, 2026. The company's stock will continue trading on NYSE American under the same ticker symbol SRXH with a new CUSIP. No fractional shares will be issued; shareholders entitled to fractions will…
Cognition Therapeutics announced that the FDA has agreed on key aspects of a Phase 3 pivotal trial design for its drug candidate zervimesine (CT1812) targeting psychosis symptoms in dementia with Lewy bodies (DLB). This alignment supports using DLB psychosis as an approvable outcome, enabling the planned registrational study to begin in mid-2027. T…
Daktronics, Inc. announced its fourth quarter and full fiscal year 2026 financial results, highlighting record net sales of $838.7 million and record orders of $860.8 million, reflecting strong demand across multiple business segments. The company achieved significant margin expansion and a positive operating income, reversing losses from the prior…
OrthoPediatrics Corp. has entered into an exclusive distribution agreement with OSSIO, Inc. to provide their innovative bio-integrative, metal-free OSSIOfiber implants to children's hospitals across the United States. These implants offer a significant advancement in pediatric orthopedic care by reducing the need for secondary surgeries associated …
VERAXA Biotech AG has expanded its R&D laboratory space in Heidelberg, Germany to support growing internal teams and upcoming development activities for its novel BiTAC-TCE and BiTAC-ADC cancer therapeutic programs. The company aims to drive these proprietary and partnered drug development programs from early discovery through early clinical develo…
MapLight Therapeutics, a clinical-stage biotech focused on CNS disorders, has appointed Martin Babler and Troy Cox to its Board of Directors, succeeding two outgoing members. The new board members bring substantial leadership experience in biotechnology, which is expected to support the company's ongoing strategy to develop innovative therapies tar…
Baker Hughes and Mantle Reach Power, backed by EnCap Energy Transition, announced a strategic agreement to develop large-scale geothermal energy projects across North America. Leveraging Baker Hughes' integrated subsurface and surface technology portfolio and Mantle Reach Power's project development and finance expertise, the collaboration aims to …
GXO Logistics, the largest pure-play contract logistics provider, has renewed its long-standing partnership with Carrefour to manage frozen supply chain operations in Belgium and Luxembourg. Leveraging advanced technology and a large logistics facility in Zellik, GXO supports Carrefour's frozen goods distribution to over 700 stores, emphasizing inn…
TScan Therapeutics will participate in a fireside chat at the upcoming H.C. Wainwright 4th Annual Cell Therapy Virtual Conference, sharing insights on their clinical-stage TCR-T therapies targeting cancer and autoimmune disorders. The company focuses on T cell receptor-engineered therapies, notably advancing treatments for hematologic malignancies …
FuelCell Energy, Inc. announces a strategic agreement with Fit Energy USA LP to supply up to 380 MW of clean, baseload on-site power for data centers, leveraging FuelCell's utility-scale fuel cell technology. The partnership supports the growing demand for reliable, low-emission power in digital infrastructure and AI applications. An initial 30 MW …
Crown Crafts, Inc. announced its financial results for the fourth quarter and full fiscal year 2026, reporting net sales of $22.4 million for Q4 and $82.3 million for the year. The company achieved a significant turnaround from a prior-year net loss to a net income of $0.3 million in the quarter and $1.8 million for the year. Gross profit margins i…
Rank One Computing Corporation (ROC) announced a definitive agreement to acquire Zuccaro Technical Consulting (ZTC), a developer of digital forensics solutions with active federal government contracts. This acquisition aims to expand ROC's Vision AI platform by integrating ZTC's digital evidence capabilities, accelerating ROC Evidence with an end-t…
Devon Energy Corporation announced the final results of its exchange offers allowing holders of certain notes issued by its subsidiary Coterra Energy Inc. to swap their notes for new notes issued by Devon and cash. The exchange offers showed high participation rates across multiple series of notes, with settlement expected by June 25, 2026. These n…
Bowman Consulting Group Ltd. has won $11.2 million in aerial acquisition contracts under the USDA's PINE Blanket Purchase Agreement, significantly expanding their federal geospatial data services. The contracts cover large acreage across multiple USDA programs and states, doubling previous contract value and demonstrating Bowman's investment in adv…
Gilat Satellite Networks has secured a multi-million dollar order to deliver customized SATCOM terminals to a European Ministry of Defense. This contract highlights Gilat's growing presence in mission-critical defense communications by providing resilient, ruggedized satellite connectivity solutions designed for demanding operational environments. …
KANZHUN LIMITED (BOSS Zhipin) has actively repurchased shares totaling nearly RMB1.94 billion in 2026, reinforcing its commitment to shareholder returns. The Board has authorized increasing the total share repurchase program to US$400 million through August 2027 and announced a policy to distribute at least 50% of adjusted net income annually via d…
UMH Properties, Inc., a REIT specializing in manufactured home communities, endorses the 21st Century ROAD to Housing Act. The legislation aims to alleviate the US housing shortage by modernizing regulations, expanding supply, reducing costs, and improving financing for manufactured homes, which will enable UMH to grow its portfolio and enhance off…
Absci Corporation announced the pricing of a $100 million underwritten offering of 13.5 million shares at $7.41 each, with participation from strategic and financial investors including Eli Lilly & Company. The proceeds will fund the development of ABS-201, an AI-designed antibody targeting androgenetic alopecia and endometriosis, and support gener…
Absci Corporation announced encouraging interim Phase 1 trial results for ABS-201, a novel antibody targeting the prolactin receptor designed to treat androgenetic alopecia (male and female pattern hair loss). The data show favorable safety and pharmacokinetics, including an estimated half-life supporting infrequent dosing. The study has progressed…
Brown & Brown, Inc., a leading insurance brokerage, announces the appointment of Neil Krauter Sr. as executive managing director of growth and specialization within its Retail segment. Krauter will focus on expanding enterprise growth, enhancing specialization, recruiting top talent, and strengthening strategic relationships globally. He will lever…
Comstock Inc., through its subsidiary Comstock Metals LLC, announced plans to establish a new industrial-scale solar panel recycling and production facility in Cambridge, Ohio. The facility will expand their capacity to recycle end-of-life solar panels and produce valuable materials like aluminum, silver, and glass beads, serving the growing Midwes…
Fiserv, Inc. announced the results of its tender offers to repurchase any and all of its outstanding 5.150% Senior Notes due 2027 and 4.400% Senior Notes due 2049. A total aggregate principal amount exceeding $1.33 billion was validly tendered by the expiration date. The company intends to accept all valid tenders and pay the specified consideratio…
MoneyHero Limited (Nasdaq: MNY) announced a 15% year-over-year revenue increase to $16.5 million in Q1 2026, driven by strong growth in its higher-margin Wealth and Insurance verticals which expanded 31%. The company achieved a 68% reduction in Adjusted EBITDA loss through structural cost discipline including AI-driven automation and technology sta…
Helus Pharma announced an underwritten offering of approximately 10.3 million common shares priced at $4.85 per share, raising gross proceeds of $50 million. The capital will be used to advance its Phase 3 candidate for major depressive disorder (HLP003) with expected data in Q4 2026, as well as its Phase 2 candidate for generalized anxiety disorde…
Helus Pharma reports significant progress in its Phase 3 clinical trial (APPROACH) of HLP003, a novel serotonergic agonist for adjunctive treatment of major depressive disorder. The trial has surpassed 86% enrollment and remains on track for topline data in Q4 2026. Prior Phase 2 data showed significant long-term efficacy and remission rates. HLP00…
